Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
- PMID: 22217446
- PMCID: PMC3349908
- DOI: 10.3858/emm.2012.44.4.021
Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
Abstract
Type 1 diabetes mellitus is caused by the autoimmune destruction of β cells within the islets. In recent years, innate immunity has been proposed to play a key role in this process. High-mobility group box 1 (HMGB1), an inflammatory trigger in a number of autoimmune diseases, activates proinflammatory responses following its release from necrotic cells. Our aim was to determine the significance of HMGB1 in the natural history of diabetes in non-obese diabetic (NOD) mice. We observed that the rate of HMGB1 expression in the cytoplasm of islets was much greater in diabetic mice compared with non-diabetic mice. The majority of cells positively stained for toll-like receptor 4 (TLR4) were β cells; few α cells were stained for TLR4. Thus, we examined the effects of anti-TLR4 antibodies on HMGB1 cell surface binding, which confirmed that HMGB1 interacts with TLR4 in isolated islets. Expression changes in HMGB1 and TLR4 were detected throughout the course of diabetes. Our findings indicate that TLR4 is the main receptor on β cells and that HMGB1 may signal via TLR4 to selectively damage β cells rather than α cells during the development of type 1 diabetes mellitus.
Figures
Similar articles
-
Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.Diabetes. 2008 Aug;57(8):2118-27. doi: 10.2337/db07-1499. Epub 2008 May 13. Diabetes. 2008. PMID: 18477810 Free PMC article.
-
Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation.Eur J Immunol. 2010 Oct;40(10):2914-24. doi: 10.1002/eji.201040601. Eur J Immunol. 2010. PMID: 20809521 Free PMC article.
-
Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability.Diabetologia. 2020 May;63(5):987-1001. doi: 10.1007/s00125-020-05105-8. Epub 2020 Feb 19. Diabetologia. 2020. PMID: 32072192 Free PMC article.
-
The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.J Autoimmun. 2016 Jul;71:26-34. doi: 10.1016/j.jaut.2016.03.006. Epub 2016 Mar 24. J Autoimmun. 2016. PMID: 27021275 Free PMC article. Review.
-
Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.Mol Biol Rep. 2021 Feb;48(2):1869-1881. doi: 10.1007/s11033-020-06130-x. Epub 2021 Jan 21. Mol Biol Rep. 2021. PMID: 33479829 Review.
Cited by
-
Advancements in innate immune regulation strategies in islet transplantation.Front Immunol. 2024 Jan 15;14:1341314. doi: 10.3389/fimmu.2023.1341314. eCollection 2023. Front Immunol. 2024. PMID: 38288129 Free PMC article. Review.
-
Toll-like Receptor 9 Gene in the Development of Type 2 Diabetes Mellitus in the Saudi Arabian Population.Biology (Basel). 2023 Nov 16;12(11):1439. doi: 10.3390/biology12111439. Biology (Basel). 2023. PMID: 37998038 Free PMC article.
-
How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk.Front Endocrinol (Lausanne). 2023 Jul 26;14:1205219. doi: 10.3389/fendo.2023.1205219. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37564976 Free PMC article. Review.
-
Protective effect of dexmedetomidine on intestinal mucosal barrier function in rats after cardiopulmonary bypass.Exp Biol Med (Maywood). 2022 Mar;247(6):498-508. doi: 10.1177/15353702211062509. Epub 2021 Dec 8. Exp Biol Med (Maywood). 2022. PMID: 34878923 Free PMC article.
-
Toll-like receptor 7 deficiency suppresses type 1 diabetes development by modulating B-cell differentiation and function.Cell Mol Immunol. 2021 Feb;18(2):328-338. doi: 10.1038/s41423-020-00590-8. Epub 2021 Jan 11. Cell Mol Immunol. 2021. PMID: 33432061 Free PMC article.
References
-
- Abdulahad DA, Westra J, Limburg PC, Kallenberg C, Bijl M. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development. Autoimmun Rev. 2010;9:661–665. - PubMed
-
- Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol. 2005;23:447–485. - PubMed
-
- Devaraj S, Tobias P, Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine. 2011;55:441–445. - PubMed
-
- Gdynia G, Keith M, Kopitz J, Bergmann M, Fassl A, Weber AN, George J, Kees T, Zentgraf HW, Wiestler OD, Schirmacher P, Roth W. Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria. Cancer Res. 2010;70:8558–8568. - PubMed
-
- Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol. 2004;173:2280–2287. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical